Brief: Living Cell Technologies Signs Services Agreement With New Zealand Biotech Nzeno Limited
24/01/2022 01:15
Jan 24 (Reuters) - Living Cell Technologies Ltd LCT.AX :
* SIGNS SERVICES AGREEMENT WITH NEW ZEALAND BIOTECH NZENO
LIMITED
* AGREEMENT TO OBTAIN TISSUE FROM PATHOGEN-FREE PIGS FOR
THIRD
CLINICAL TRIAL OF NTCELL
Source text for Eikon: ID:nASX8FSpWm
Further company coverage: LCT.AX
((reuters.briefs@thomsonreuters.com;))
Recent news on Algorae Pharmaceuticals
See all newsBrief: Algorae Pharmaceuticals Executes License & Supply Agreement With Torrent Pharma
Brief: Algorae Pharmaceuticals And Zydus Enter Exclusive Commercial Agreement
Brief: Algorae Pharmaceuticals Raises A$3.9 Million At A$0.012 Per Share
Brief: Algorae Pharmaceuticals Says TGA Accepts Initial Registration Dossier For Evaluation
Brief: Algorae Pharmaceuticals Partners With Peter Maccallum Cancer Centre For Second AI-Driven Drug Synergy Screening Program